{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T11:43:39Z","timestamp":1702640619842},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00108-022-01409-6","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T14:03:59Z","timestamp":1665410639000},"page":"1115-1125","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Einfluss der klonalen H\u00e4matopoese auf nicht-h\u00e4matologische Erkrankungen und Alterungsprozesse"],"prefix":"10.1007","volume":"63","author":[{"given":"Michael A.","family":"Rieger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"issue":"6255","key":"1409_CR1","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.aab4082","volume":"349","author":"I Martincorena","year":"2015","unstructured":"Martincorena\u00a0I, Campbell\u00a0PJ (2015) Somatic mutation in cancer and normal cells. Science 349(6255):1483\u20131489","journal-title":"Science"},{"issue":"7779","key":"1409_CR2","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-019-1672-7","volume":"574","author":"H Lee-Six","year":"2019","unstructured":"Lee-Six\u00a0H, Olafsson\u00a0S, Ellis\u00a0P et al (2019) The landscape of somatic mutation in normal colorectal epithelial cells. Nature 574(7779):532\u2013537","journal-title":"Nature"},{"issue":"1","key":"1409_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma\u00a0DP, Bejar\u00a0R, Jaiswal\u00a0S et\u00a0al (2015) Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood 126(1):9\u201316","journal-title":"Blood"},{"issue":"3","key":"1409_CR4","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/ehf2.13297","volume":"8","author":"KC Kiefer","year":"2021","unstructured":"Kiefer\u00a0KC, Cremer\u00a0S, Pardali\u00a0E et al (2021) Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality. ESC Heart Fail 8(3):1873\u20131884","journal-title":"ESC Heart Fail"},{"key":"1409_CR5","doi-asserted-by":"publisher","first-page":"12484","DOI":"10.1038\/ncomms12484","volume":"7","author":"AL Young","year":"2016","unstructured":"Young\u00a0AL, Challen\u00a0GA, Birmann\u00a0BM et al (2016) Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat Commun 7:12484","journal-title":"Nat Commun"},{"issue":"26","key":"1409_CR6","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese\u00a0G, K\u00e4hler\u00a0AK, Handsaker\u00a0RE et al (2014) Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N\u00a0Engl J Med 371(26):2477\u20132487","journal-title":"N Engl J Med"},{"issue":"26","key":"1409_CR7","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal\u00a0S, Fontanillas\u00a0P, Flannick\u00a0J et al (2014) Age-related clonal hematopoiesis associated with adverse outcomes. N\u00a0Engl J Med 371(26):2488\u20132498","journal-title":"N Engl J Med"},{"issue":"2","key":"1409_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal\u00a0S, Natarajan\u00a0P, Silver\u00a0AJ et\u00a0al (2017) Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N\u00a0Engl J Med 377(2):111\u2013121","journal-title":"N Engl J Med"},{"key":"1409_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.exphem.2019.12.006","volume":"83","author":"E Pardali","year":"2020","unstructured":"Pardali\u00a0E, Dimmeler\u00a0S, Zeiher\u00a0AM et\u00a0al (2020) Clonal hematopoiesis, aging, and cardiovascular diseases. Exp Hematol 83:95\u2013104","journal-title":"Exp Hematol"},{"issue":"4","key":"1409_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jacc.2019.06.007","volume":"74","author":"P Libby","year":"2019","unstructured":"Libby\u00a0P, Sidlow\u00a0R, Lin\u00a0AE et\u00a0al (2019) Clonal hematopoiesis: crossroads of aging, cardiovascular disease, and cancer: JACC review topic of the week. J\u00a0Am Coll Cardiol 74(4):567\u2013577","journal-title":"J Am Coll Cardiol"},{"issue":"6327","key":"1409_CR11","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster\u00a0JJ, MacLauchlan\u00a0S, Zuriaga\u00a0MA et\u00a0al (2017) Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355(6327):842\u2013847","journal-title":"Science"},{"issue":"1","key":"1409_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","volume":"67","author":"P Libby","year":"2021","unstructured":"Libby\u00a0P (2021) Inflammation in atherosclerosis\u2014no longer a\u00a0theory. Clin Chem 67(1):131\u2013142","journal-title":"Clin Chem"},{"issue":"1","key":"1409_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","volume":"4","author":"L Dorsheimer","year":"2019","unstructured":"Dorsheimer\u00a0L, Assmus\u00a0B, Rasper\u00a0T et\u00a0al (2019) Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure. JAMA Cardiol 4(1):25\u201333","journal-title":"JAMA Cardiol"},{"issue":"3","key":"1409_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/eurheartj\/ehaa845","volume":"42","author":"B Assmus","year":"2021","unstructured":"Assmus\u00a0B, Cremer\u00a0S, Kirschbaum\u00a0K et al (2021) Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations. Eur Heart\u00a0J 42(3):257\u2013265","journal-title":"Eur Heart J"},{"issue":"7714","key":"1409_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","volume":"559","author":"S Abelson","year":"2018","unstructured":"Abelson\u00a0S, Collord\u00a0G, Ng\u00a0SWK et\u00a0al (2018) Prediction of acute myeloid leukaemia risk in healthy individuals. Nature 559(7714):400\u2013404","journal-title":"Nature"},{"issue":"4","key":"1409_CR16","doi-asserted-by":"publisher","first-page":"e003003","DOI":"10.1161\/CIRCGEN.120.003003","volume":"13","author":"S Cremer","year":"2020","unstructured":"Cremer\u00a0S, Kirschbaum\u00a0K, Berkowitsch\u00a0A et\u00a0al (2020) Multiple somatic mutations for clonal hematopoiesis are associated with increased mortality in patients with chronic heart failure. Circ Genom Precis Med 13(4):e3003","journal-title":"Circ Genom Precis Med"},{"issue":"14","key":"1409_CR17","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2021.02.028","volume":"77","author":"DA Pascual-Figal","year":"2021","unstructured":"Pascual-Figal\u00a0DA, Bayes-Genis\u00a0A, D\u00edez-D\u00edez\u00a0M et al (2021) Clonal hematopoiesis and risk of progression of heart failure with reduced left ventricular ejection fraction. J\u00a0Am Coll Cardiol 77(14):1747\u20131759","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1409_CR18","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","volume":"71","author":"S Sano","year":"2018","unstructured":"Sano\u00a0S, Oshima\u00a0K, Wang\u00a0Y et al (2018) Tet2-mediated clonal hematopoiesis accelerates heart failure through a\u00a0mechanism involving the IL-1\u03b2\/NLRP3 inflammasome. J\u00a0Am Coll Cardiol 71(8):875\u2013886","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1409_CR19","doi-asserted-by":"publisher","first-page":"e135204","DOI":"10.1172\/jci.insight.135204","volume":"5","author":"Y Wang","year":"2020","unstructured":"Wang\u00a0Y, Sano\u00a0S, Yura\u00a0Y et al (2020) Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction. JCI Insight 5(6):e135204","journal-title":"JCI Insight"},{"issue":"8","key":"1409_CR20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/eurheartj\/ehz591","volume":"41","author":"S Mas-Peiro","year":"2020","unstructured":"Mas-Peiro\u00a0S, Hoffmann\u00a0J, Fichtlscherer\u00a0S et al (2020) Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation. Eur Heart\u00a0J 41(8):933\u2013939","journal-title":"Eur Heart J"},{"issue":"10","key":"1409_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamacardio.2020.2468","volume":"5","author":"WT Abplanalp","year":"2020","unstructured":"Abplanalp\u00a0WT, Mas-Peiro\u00a0S, Cremer\u00a0S et al (2020) Association of clonal hematopoiesis of indeterminate potential with inflammatory gene expression in patients with severe degenerative aortic valve stenosis or chronic postischemic heart failure. JAMA Cardiol 5(10):1\u20136","journal-title":"JAMA Cardiol"},{"issue":"7325","key":"1409_CR22","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature09586","volume":"468","author":"M Ko","year":"2010","unstructured":"Ko\u00a0M, Huang\u00a0Y, Jankowska\u00a0AM et al (2010) Impaired hydroxylation of 5\u2011methylcytosine in myeloid cancers with mutant TET2. Nature 468(7325):839\u2013843","journal-title":"Nature"},{"issue":"22","key":"1409_CR23","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau\u00a0F, Dupont\u00a0S, Della Valle\u00a0V et\u00a0al (2009) Mutation in TET2 in myeloid cancers. N\u00a0Engl J Med 360(22):2289\u20132301","journal-title":"N Engl J Med"},{"issue":"7","key":"1409_CR24","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.3324\/haematol.2019.224402","volume":"105","author":"L Dorsheimer","year":"2020","unstructured":"Dorsheimer\u00a0L, Assmus\u00a0B, Rasper\u00a0T et\u00a0al (2020) Hematopoietic alterations in chronic heart failure patients by somatic mutations leading to clonal hematopoiesis. Haematologica 105(7):e328\u2013e332","journal-title":"Haematologica"},{"issue":"3","key":"1409_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","volume":"123","author":"S Sano","year":"2018","unstructured":"Sano\u00a0S, Oshima\u00a0K, Wang\u00a0Y et al (2018) CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease. Circ Res 123(3):335\u2013341","journal-title":"Circ Res"},{"issue":"1","key":"1409_CR26","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/s41467-019-09541-y","volume":"10","author":"X Yue","year":"2019","unstructured":"Yue\u00a0X, Lio\u00a0C\u2011WJ, Samaniego-Castruita\u00a0D et al (2019) Loss of TET2 and TET3 in regulatory T cells unleashes effector function. Nat Commun 10(1):2011","journal-title":"Nat Commun"},{"issue":"1","key":"1409_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng.1009","volume":"44","author":"GA Challen","year":"2011","unstructured":"Challen\u00a0GA, Sun\u00a0D, Jeong\u00a0M et\u00a0al (2011) Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 44(1):23\u201331","journal-title":"Nat Genet"},{"issue":"9","key":"1409_CR28","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ng.3610","volume":"48","author":"X Zhang","year":"2016","unstructured":"Zhang\u00a0X, Su\u00a0J, Jeong\u00a0M et al (2016) DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells. Nat Genet 48(9):1014\u20131023","journal-title":"Nat Genet"},{"issue":"4","key":"1409_CR29","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.4049\/jimmunol.0802960","volume":"183","author":"CJ Gamper","year":"2009","unstructured":"Gamper\u00a0CJ, Agoston\u00a0AT, Nelson\u00a0WG et al (2009) Identification of DNA methyltransferase 3a as a\u00a0T cell receptor-induced regulator of th1 and th2 differentiation. J\u00a0Immunol 183(4):2267","journal-title":"J Immunol"},{"issue":"7","key":"1409_CR30","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/ni.3464","volume":"17","author":"X Li","year":"2016","unstructured":"Li\u00a0X, Zhang\u00a0Q, Ding\u00a0Y et\u00a0al (2016) Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity. Nat Immunol 17(7):806\u2013815","journal-title":"Nat Immunol"},{"issue":"8","key":"1409_CR31","doi-asserted-by":"publisher","first-page":"E1490","DOI":"10.1073\/pnas.1616420114","volume":"114","author":"C Leoni","year":"2017","unstructured":"Leoni\u00a0C, Montagner\u00a0S, Rinaldi\u00a0A et\u00a0al (2017) Dnmt3a restrains mast cell inflammatory responses. Proc Natl Acad Sci U S\u00a0A 114(8):E1490\u2013E1499","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1409_CR32","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jamacardio.2020.2468","volume":"5","author":"WT Abplanalp","year":"2020","unstructured":"Abplanalp\u00a0WT, Mas-Peiro\u00a0S, Cremer\u00a0S et al (2020) Association of clonal hematopoiesis of indeterminate potential with inflammatory gene expression in patients with severe degenerative aortic valve stenosis or chronic postischemic heart failure. JAMA Cardiol 5(10):1170\u20131175","journal-title":"JAMA Cardiol"},{"issue":"6","key":"1409_CR33","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1074\/jbc.M110.200774","volume":"286","author":"A Kirabo","year":"2011","unstructured":"Kirabo\u00a0A, Embury\u00a0J, Kiss\u00a0R et al (2011) The stilbenoid tyrosine kinase inhibitor, G6, suppresses Jak2-V617F-mediated human pathological cell growth in vitro and in vivo. J\u00a0Biol Chem 286(6):4280\u20134291","journal-title":"J Biol Chem"},{"issue":"14","key":"1409_CR34","doi-asserted-by":"publisher","first-page":"e93735","DOI":"10.1172\/jci.insight.93735","volume":"2","author":"T Sivasubramaniyam","year":"2017","unstructured":"Sivasubramaniyam\u00a0T, Schroer\u00a0SA, Li\u00a0A et al (2017) Hepatic JAK2 protects against atherosclerosis through circulating IGF\u20111. JCI Insight 2(14):e93735","journal-title":"JCI Insight"},{"issue":"2","key":"1409_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1751-553X.2010.01275.x","volume":"33","author":"SG Xavier","year":"2011","unstructured":"Xavier\u00a0SG, Gadelha\u00a0T, Rezende\u00a0SM et\u00a0al (2011) JAK2V617F mutation in patients with thrombosis: to screen or not to screen? Int J Lab Hem 33(2):117\u2013124","journal-title":"Int J Lab Hem"},{"issue":"11","key":"1409_CR36","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/CIRCRESAHA.118.313283","volume":"123","author":"W Wang","year":"2018","unstructured":"Wang\u00a0W, Liu\u00a0W, Fidler\u00a0T et\u00a0al (2018) Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2 V617F mice. Circ Res 123(11):e35\u2013e47","journal-title":"Circ Res"},{"issue":"6","key":"1409_CR37","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jacbts.2019.05.013","volume":"4","author":"S Sano","year":"2019","unstructured":"Sano\u00a0S, Wang\u00a0Y, Yura\u00a0Y et al (2019) JAK2V617F-mediated clonal hematopoiesis accelerates pathological remodeling in murine heart failure. JACC Basic Transl Sci 4(6):684\u2013697","journal-title":"JACC Basic Transl Sci"},{"issue":"5","key":"1409_CR38","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.stem.2018.10.004","volume":"23","author":"JI Hsu","year":"2018","unstructured":"Hsu\u00a0JI, Dayaram\u00a0T, Tovy\u00a0A et\u00a0al (2018) PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy. Cell Stem Cell 23(5):700\u2013713.e6","journal-title":"Cell Stem Cell"},{"issue":"6","key":"1409_CR39","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCRESAHA.121.319314","volume":"129","author":"Y Yura","year":"2021","unstructured":"Yura\u00a0Y, Miura-Yura\u00a0E, Katanasaka\u00a0Y et al (2021) The cancer therapy-related clonal hematopoiesis driver gene Ppm1d promotes inflammation and non-ischemic heart failure in mice. Circ Res 129(6):684\u2013698","journal-title":"Circ Res"},{"issue":"13","key":"1409_CR40","doi-asserted-by":"publisher","first-page":"e146076","DOI":"10.1172\/jci.insight.146076","volume":"6","author":"S Sano","year":"2021","unstructured":"Sano\u00a0S, Wang\u00a0Y, Ogawa\u00a0H et al (2021) TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a\u00a0neutrophil-mediated cytotoxic response. JCI Insight 6(13):e146076","journal-title":"JCI Insight"},{"issue":"5","key":"1409_CR41","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.cell.2021.01.049","volume":"184","author":"A Heyde","year":"2021","unstructured":"Heyde\u00a0A, Rohde\u00a0D, McAlpine\u00a0CS et\u00a0al (2021) Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis. Cell 184(5):1348\u20131361.e22","journal-title":"Cell"},{"issue":"3","key":"1409_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1182\/blood.2021013531","volume":"139","author":"PG Miller","year":"2022","unstructured":"Miller\u00a0PG, Qiao\u00a0D, Rojas-Quintero\u00a0J et al (2022) Association of clonal hematopoiesis with chronic obstructive pulmonary disease. Blood 139(3):357\u2013368","journal-title":"Blood"},{"issue":"3","key":"1409_CR43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41588-018-0342-2","volume":"51","author":"P Sakornsakolpat","year":"2019","unstructured":"Sakornsakolpat\u00a0P, Prokopenko\u00a0D, Lamontagne\u00a0M et al (2019) Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations. Nat Genet 51(3):494\u2013505","journal-title":"Nat Genet"},{"issue":"13","key":"1409_CR44","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3390\/cells11132121","volume":"11","author":"S Kuhnert","year":"2022","unstructured":"Kuhnert\u00a0S, Mansouri\u00a0S, Rieger\u00a0MA et\u00a0al (2022) Association of clonal hematopoiesis of indeterminate potential with inflammatory gene expression in patients with COPD. Cells 11(13):2121","journal-title":"Cells"},{"issue":"6","key":"1409_CR45","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41591-021-01357-y","volume":"27","author":"NJ Dharan","year":"2021","unstructured":"Dharan\u00a0NJ, Yeh\u00a0P, Bloch\u00a0M et al (2021) HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults. Nat Med 27(6):1006\u20131011","journal-title":"Nat Med"},{"issue":"1","key":"1409_CR46","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41598-021-04308-2","volume":"12","author":"AG Bick","year":"2022","unstructured":"Bick\u00a0AG, Popadin\u00a0K, Thorball\u00a0CW et\u00a0al (2022) Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV. Sci Rep 12(1):577","journal-title":"Sci Rep"},{"issue":"14","key":"1409_CR47","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1080\/10428194.2019.1633631","volume":"60","author":"JD Kaner","year":"2019","unstructured":"Kaner\u00a0JD, Thibaud\u00a0S, Jasra\u00a0S et\u00a0al (2019) HIV portends a\u00a0poor prognosis in myelodysplastic syndromes. Leuk Lymphoma 60(14):3529\u20133535","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"1409_CR48","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1038\/s41467-021-26138-6","volume":"12","author":"KL Bolton","year":"2021","unstructured":"Bolton\u00a0KL, Koh\u00a0Y, Foote\u00a0MB et al (2021) Clonal hematopoiesis is associated with risk of severe Covid-19. Nat Commun 12(1):5975","journal-title":"Nat Commun"},{"issue":"4","key":"1409_CR49","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1097\/HS9.0000000000000453","volume":"4","author":"E Hameister","year":"2020","unstructured":"Hameister\u00a0E, Stolz\u00a0SM, Fuhrer\u00a0Y et al (2020) Clonal hematopoiesis in hospitalized elderly patients with COVID-19. Hemasphere 4(4):e453","journal-title":"Hemasphere"},{"issue":"4","key":"1409_CR50","doi-asserted-by":"publisher","first-page":"108326","DOI":"10.1016\/j.celrep.2020.108326","volume":"33","author":"JJ Fuster","year":"2020","unstructured":"Fuster\u00a0JJ, Zuriaga\u00a0MA, Zorita\u00a0V et al (2020) TET2-loss-of-function-driven clonal hematopoiesis exacerbates experimental insulin resistance in aging and obesity. Cell Rep 33(4):108326","journal-title":"Cell Rep"},{"issue":"2","key":"1409_CR51","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","volume":"141","author":"AG Bick","year":"2020","unstructured":"Bick\u00a0AG, Pirruccello\u00a0JP, Griffin\u00a0GK et\u00a0al (2020) Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis. Circulation 141(2):124\u2013131","journal-title":"Circulation"},{"issue":"5","key":"1409_CR52","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/cvr\/cvz032","volume":"115","author":"AP Patel","year":"2019","unstructured":"Patel\u00a0AP, Natarajan\u00a0P (2019) Completing the genetic spectrum influencing coronary artery disease: from germline to somatic variation. Cardiovasc Res 115(5):830\u2013843","journal-title":"Cardiovasc Res"},{"issue":"5","key":"1409_CR53","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","volume":"7","author":"EC Svensson","year":"2022","unstructured":"Svensson\u00a0EC, Madar\u00a0A, Campbell\u00a0CD et al (2022) TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial. JAMA Cardiol 7(5):521\u2013528","journal-title":"JAMA Cardiol"},{"issue":"6","key":"1409_CR54","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","volume":"170","author":"L Cimmino","year":"2017","unstructured":"Cimmino\u00a0L, Dolgalev\u00a0I, Wang\u00a0Y et al (2017) Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell 170(6):1079\u20131095.e20","journal-title":"Cell"},{"issue":"1","key":"1409_CR55","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-021-22053-y","volume":"12","author":"T Fujino","year":"2021","unstructured":"Fujino\u00a0T, Goyama\u00a0S, Sugiura\u00a0Y et al (2021) Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt\/mTOR pathway. Nat Commun 12(1):1826","journal-title":"Nat Commun"},{"issue":"1","key":"1409_CR56","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1038\/s41467-020-17942-7","volume":"11","author":"S Valletta","year":"2020","unstructured":"Valletta\u00a0S, Thomas\u00a0A, Meng\u00a0Y et al (2020) Micro-environmental sensing by bone marrow stroma identifies IL\u20116 and TGF\u03b21 as regulators of hematopoietic ageing. Nat Commun 11(1):4075","journal-title":"Nat Commun"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01409-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-022-01409-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01409-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T03:02:22Z","timestamp":1667098942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-022-01409-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1007\/s00108-022-01409-6","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"assertion":[{"value":"2 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.A.\u00a0Rieger gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}